QUIA PHARMA AB Logo

QUIA PHARMA AB

QUIA | ST

Overview

Corporate Details

ISIN(s):
SE0020678159
LEI:
967600JUP7EI6X9D2Z44
Country:
Sweden
Address:
Virdings Allé 32 B, 754 50 Uppsala
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

QUIA PHARMA AB is a pharmaceutical development company focused on its proprietary and patented drug delivery platform, Uni-Qleaver®. This platform is based on a unique, releasable pegylation technology designed to create improved and patentable versions of both new and existing, approved drugs. The company engages in the research, development, and commercialization of a pipeline of enhanced medicines, aiming to improve the efficacy and properties of pharmaceutical treatments.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for QUIA PHARMA AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all QUIA PHARMA AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for QUIA PHARMA AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland RVU
Saniona Logo
Biopharma developing medicines for epilepsy and neurological disorders using ion channel research.
Denmark SANION
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom SCLP
Scandion Oncology A/S Logo
A liquidated biotech that developed oral drugs to overcome cancer treatment resistance.
Denmark SCOL
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland SLV
Sensorion Logo
Clinical-stage biotech developing novel therapies for hearing loss, vertigo, and tinnitus.
France ALSEN
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom SBTX